InMed Pharmaceuticals Inc. Sample Contracts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 24, 2023, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AT THE MARKET OFFERING AGREEMENT April 7, 2022At the Market Offering Agreement • April 7th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
InMed Pharmaceuticals Inc., a corporation organized under the laws of British Columbia, Canada (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
COMMON SHARES OF INMED PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 6th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
The undersigned, InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of InMed Pharmaceuticals Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative”) and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
1,780,000 COMMON SHARES AND 1,780,000 WARRANTS OF INMED PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
The undersigned, InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of InMed Pharmaceuticals Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative”) and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
STANDBY EQUITY PURCHASE AGREEMENTStandby Equity Purchase Agreement • December 18th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
THIS STANDBY EQUITY PURCHASE AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of December 13, 2024, is made by and between YA II PN, LTD., a Cayman Islands exempt limited company (the “Investor”), and INMED PHARMACEUTICALS INC., a company organized under the laws of British Columbia, Canada (the “Company”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 30th, 2025 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 24, 2025, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SERIES A COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Security Agreement • June 30th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Pre-Funded Common Shares Purchase Warrant • June 6th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Securities Agreement • November 22nd, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 5th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia (the “Company”), with offices at Suite 310, 815 West Hastings St., Vancouver, British Columbia V6C 1B4 Facsimile: (604) 683-2506
COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Common Shares Purchase Warrant • November 12th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 16, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 9th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the “Company”)
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 26, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 6th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 1, 2022, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Security Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 30th, 2025 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 24, 2025, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • June 30th, 2025 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Effective Date, provided that, if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as de
CONSULTING AGREEMENTConsulting Agreement • September 29th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
InMed Pharmaceuticals Inc., a corporation registered in the Province of British Columbia and having its principal place of business at 310-815 W. Hastings St., Vancouver, BC, V6C 1B4,
Amended and Restated Agreement and Plan of ReorganizationAgreement and Plan of Reorganization • October 13th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Amended and Restated Agreement and Plan of Reorganization (this “Agreement”), dated as of October [__], 2021, is entered into among InMed Pharmaceuticals Inc., a British Columbia, Canada corporation (“Parent”), BayMedica, LLC, a Delaware limited liability company and indirect wholly owned subsidiary of Parent (“Merger Sub”), BayMedica, Inc., a Nevada corporation (“Company”), BM REP, LLC, a Nevada limited liability company, solely in its capacity as Stockholder Representative (“Stockholder Representative”), Philip J. Barr, The Shane A. Johnson Trust DTD April 18, 1997, as amended, Shane A. Johnson TTEE, Shane A. Johnson, Charles K. Marlowe, and the other Stockholders listed on the signature pages hereto. This Agreement amends and restates in its entirety that certain Agreement and Plan of Reorganization, dated as of September 10, 2021, entered into among Parent, Merger Sub, Company, Stockholder Representative and the Stockholders listed on the signature pages thereto (the “Original
FORM OF SERIES A COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Warrant Agreement • September 24th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common shares of the Company (the “Common Shares”). The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
THIS AGREEMENT (the “Agreement”) made as of the 28th day of October, 2015 (the “Effective Date”),Purchase and Sale Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia, with offices at Suite 350, 409 Granville St, Vancouver, B.C.V6C 1T2]
SHARE PURCHASE AGREEMENT AMONG MERIDEX SOFTWARE CORPORATION, BIOGEN SCIENCES INC. AND THE SHAREHOLDERS OF BIOGEN SCIENCES INC.Share Purchase Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
MERIDEX SOFTWARE CORPORATION, a corporation organized pursuant to the laws of British Columbia, and with an address at 350-409 Granville Street, Vancouver, BC V6C 1T2
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 - 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
TECHNOLOGY ASSIGNMENT AGREEMENTTechnology Assignment Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
STOCK OPTION PLAN - OPTION AGREEMENTStock Option Agreement • March 5th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Option Agreement is entered into between INMED PHARMACEUTICALS INC. (the “Company”) and the Optionee named below pursuant to the Company Stock Option Plan (the “Plan”), a copy of which is attached hereto, and confirms that:
SCIENTIFIC ADVISORY BOARD CONSULTING AGREEMENTScientific Advisory Board Consulting Agreement • September 30th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia having an office at Suite 1445, 885 W. Georgia Street, Vancouver, British Columbia, Canada V6C 3E8
EMPLOYMENT AGREEMENTEmployment Agreement • December 7th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the “Company”)
VIA EMAIL: eadams@inmedpharma.comEmployment Agreement • July 18th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
AMENDMENT NO. 1 TO TECHNOLOGY ASSIGNMENT AGREEMENTTechnology Assignment Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
InMed Pharmaceuticals Inc. Suite 310 – 815 W. Hastings Street Vancouver, British Columbia V6C 1B4At the Market Offering Agreement • June 28th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
Reference is made to the At The Market Offering Agreement, dated as of April 7, 2022 (the “ATM Agreement”), between InMed Pharmaceuticals Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This letter (the “Amendment”) constitutes an agreement between the Company and Wainwright to amend the ATM Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.
PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Security Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 26, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of October 24, 2023, by
STOCK OPTION PLAN - OPTION AGREEMENTStock Option Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Option Agreement is entered into between INMED PHARMACEUTICALS INC. (the "Company") and the Optionee named below pursuant to the Company Stock Option Plan (the "Plan"), a copy of which is attached hereto, and confirms that:
CONSULTING AGREEMENTConsulting Agreement • September 30th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
InMed Pharmaceuticals Inc., a corporation registered in the Province of British Columbia and having its principal place of business at 310-815 W. Hastings St., Vancouver, BC, V6C 1B4,